Ovol1 Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GSK-J4 | 1373423-53-0 | sc-507551 | 100 mg | $1275.00 | ||
GSK-J4 is a potent inhibitor of histone demethylase JMJD3. By inhibiting JMJD3, GSK-J4 indirectly modulates Ovol1 expression through epigenetic regulation. The compound's specificity for JMJD3 ensures precise control over the pathway, subsequently influencing Ovol1 expression and function. | ||||||
JIB 04 | 199596-05-9 | sc-397040 | 20 mg | $177.00 | ||
JIB-04 is a histone demethylase inhibitor targeting KDM5 enzymes. By inhibiting KDM5, JIB-04 indirectly modulates Ovol1 expression through epigenetic regulation. The compound's specificity for KDM5 ensures precise control over the pathway, subsequently influencing Ovol1 expression and function. | ||||||
PFI-1 | 1403764-72-6 | sc-478504 | 5 mg | $98.00 | ||
PFI-1 is a selective BET bromodomain inhibitor affecting BRD4. By inhibiting BRD4, PFI-1 indirectly modulates Ovol1 expression through interference with the BET pathway. The compound's specificity for BRD4 ensures precise control over the pathway, subsequently influencing Ovol1 expression and function. | ||||||
GSK126 | 1346574-57-9 | sc-490133 sc-490133A sc-490133B | 1 mg 5 mg 10 mg | $92.00 $243.00 $306.00 | ||
GSK126 is a potent and selective inhibitor of EZH2, a component of the Polycomb Repressive Complex 2. By inhibiting EZH2, GSK126 indirectly modulates Ovol1 expression through epigenetic regulation. The compound's specificity for EZH2 ensures precise control over the pathway, subsequently influencing Ovol1 expression and function. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
I-BET151 is a selective BET bromodomain inhibitor affecting BRD2, BRD3, and BRD4. By inhibiting these bromodomain proteins, I-BET151 indirectly modulates Ovol1 expression through interference with the BET pathway. The compound's specificity for these proteins ensures precise control over the pathway, subsequently influencing Ovol1 expression and function. | ||||||
UNC 1215 | 1415800-43-9 | sc-475020 | 10 mg | $380.00 | ||
UNC1215 is a potent inhibitor of the histone methyltransferase G9a. By inhibiting G9a, UNC1215 indirectly modulates Ovol1 expression through epigenetic regulation. The compound's specificity for G9a ensures precise control over the pathway, subsequently influencing Ovol1 expression and function. | ||||||